Thrombotic microangiopathy in blood and marrow transplant patients receiving tacrolimus or cyclosporine A. (Q44272977)

1 December 2017

Thrombotic microangiopathy in blood and marrow transplant patients receiving tacrolimus or cyclosporine A. (English)

1 reference

1 December 2017

1 reference

Clarence Sarkodee-Adoo

1

1 reference

1 December 2017

Dan Sotirescu

2

1 reference

1 December 2017

Lyle Sensenbrenner

3

1 reference

1 December 2017

Aaron P Rapoport

4

1 reference

1 December 2017

Michele Cottler-Fox

5

1 reference

1 December 2017

Guido Tricot

6

1 reference

1 December 2017

Kathy Ruehle

7

1 reference

1 December 2017

Barry Meisenberg

8

1 reference

1 December 2017

1 January 2003

1 reference

1 December 2017

1 reference

1 December 2017

43

1 reference

1 December 2017

1

1 reference

1 December 2017

78-84

1 reference

Clinical outcome after conversion to FK 506 (tacrolimus) therapy for acute graft-versus-host disease resistant to cyclosporine or for cyclosporine-associated toxicities

1 December 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2003.00282.X

Microangiopathy in kidney and simultaneous pancreas/kidney recipients treated with tacrolimus: evidence of endothelin and cytokine involvement

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2003.00282.X

Thrombotic microangiopathy: a new dose-limiting toxicity of high-dose sequential chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2003.00282.X

Thrombotic microangiopathy associated with reactivation of human herpesvirus-6 following high-dose chemotherapy with autologous bone marrow transplantation in young children

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2003.00282.X

BMT: Bone Marrow Transplant Associated Thrombotic Microangiopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2003.00282.X

The clinical features, risk factors and outcome of thrombotic thrombocytopenic purpura occurring after bone marrow transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2003.00282.X

Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2003.00282.X

von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2003.00282.X

Pulmonary veno-occlusive disease accompanied by microangiopathic hemolytic anemia 1 year after a second bone marrow transplantation for acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2003.00282.X

Thrombotic microangiopathy following allogeneic bone marrow transplantation is associated with intensive graft-versus-host disease prophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2003.00282.X

Thrombotic thrombocytopenic purpura-like syndromes following bone marrow transplantation: an analysis of associated conditions and clinical outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2003.00282.X

Thrombotic thrombocytopenic purpura without any evidence of thrombotic lesions at autopsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2003.00282.X

Inhibition of calpain blocks platelet secretion, aggregation, and spreading

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2003.00282.X

Calpain activity in bone marrow transplant-associated thrombotic thrombocytopenic purpura

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2003.00282.X

Fatal thrombotic thrombocytopenic purpura as a rare complication following allogeneic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2003.00282.X

Questionable efficacy of plasma exchange for thrombotic thrombocytopenic purpura after bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2003.00282.X

Plasmapheresis for thrombotic thrombocytopenic purpura following bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2003.00282.X

Cyclosporine-associated thrombotic microangiopathy in renal allografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2003.00282.X

Severe thrombotic microangiopathy: an infrequent complication of bone marrow transplantation. Gruppo Italiano Trapianto Midollo Osseo (GITMO)

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2003.00282.X

von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2003.00282.X

The role of early renal biopsy in cyclosporin induced thrombotic microangiopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2003.00282.X

10.1046/J.1537-2995.2003.00282.X

21 January 2018

Identifiers

DOI

1 reference

1 December 2017

1 reference